Shanthala FMCG Reports ₹7.61 Crore Cash Impairment

Shanthala FMCG Products Limited reported a ₹5.89 crore loss for FY26 after booking a ₹7.61 crore impairment on customer cash that a forensic audit found had been collected but not deposited in its bank accounts. The finding led to the removal of Chief Financial Officer Yogish Mallya and a qualified audit opinion.

What did the forensic audit find at Shanthala FMCG?

The forensic audit and investigation report dated October 9, 2026 found that ₹7.61 crore collected in cash from customers during the financial year had not been deposited into Shanthala FMCG's bank accounts. The company said the amount was identified during the audit exercise and was treated as recoverable from former CFO Yogish Mallya.

The disclosure said Mallya had responsibility for day-to-day financial operations and had access and authority over the company's financial transactions and banking operations. Shanthala FMCG's board cited alleged misappropriation of funds while recording the management change.

The company recognised the ₹7.61 crore as a recoverable amount from the former CFO following the forensic findings and a board resolution. However, it also created a full allowance against this receivable, saying that recovery was uncertain. This resulted in an equal impairment loss under exceptional items in the standalone profit and loss statement.

The reported amount has appeared in some company disclosures as ₹760.79 lakh, which is equivalent to about ₹7.61 crore. Earlier references to ₹794 lakh of customer cash differ from the final FY26 figure disclosed alongside the impairment and audit observations.

Why did Shanthala FMCG replace its chief financial officer?

Shanthala FMCG removed Yogish Mallya as CFO effective October 31, 2026, citing alleged misappropriation identified through the forensic review. Ratnakar Rai was appointed as CFO from the same date.

A board outcome dated November 2 also recorded the management change and referred to alleged misappropriation of ₹760.79 lakh. The decision followed the forensic audit report dated October 9, 2026, which had identified the customer cash collection issue.

The company separately disclosed an extension-related matter for its annual general meeting. That filing did not state that the CFO change or forensic findings were the reason for the extension, so the two disclosures remain separate based on the information provided.

How did the impairment affect Shanthala FMCG's FY26 financial results?

The ₹7.61 crore impairment moved Shanthala FMCG from a profit before tax and exceptional items of ₹2.29 crore to a loss before tax of ₹5.32 crore for the year ended March 31, 2026. The company reported a post-tax loss of ₹5.89 crore, compared with a post-tax profit of ₹96.53 lakh in FY25.

The company reported FY26 consolidated revenue of ₹58.8 crore, up 11.5% from the preceding year, according to the disclosure. The revenue increase did not prevent the annual loss because the exceptional impairment was substantially larger than the profit generated before exceptional items.

Net worth declined to ₹16.9 crore following the reported loss. For investors, the distinction between operating performance and the exceptional item is material: the company reported a pre-exceptional profit, but the full impairment of the amount deemed uncertain to recover changed the final annual result.

What were the auditor's observations and related-party findings?

Kale Malde & Co. issued a qualified opinion on Shanthala FMCG's standalone financial results for the year ended March 31, 2026. The auditor said it did not have sufficient appropriate audit evidence regarding recovery of the ₹7.61 crore amount from the former CFO.

Because recoverability could not be established, the auditor said it could not determine whether further adjustments or disclosures were required in the financial statements. The qualified opinion is significant because it relates directly to the amount that was recognised as a receivable and then fully impaired.

The disclosures also identified ₹5.69 crore transferred during the year to two related parties without the required approvals of the audit committee and board. Of this amount, ₹0.58 crore was stated to remain outstanding.

These findings concern governance controls as well as financial reporting. The reported absence of required approvals for related-party transfers adds a separate issue to the customer cash matter, although the company disclosed them within the same set of FY26 audit-linked developments.

What does the disclosure mean for investors and company operations?

The disclosures show that Shanthala FMCG's FY26 loss was primarily shaped by an exceptional impairment rather than by the revenue line alone. Revenue rose 11.5% to ₹58.8 crore, while the impairment exceeded the company's ₹2.29 crore profit before tax and exceptional items.

The appointment of a new CFO takes place alongside the reported forensic findings, qualified audit opinion and related-party approval observations. The available disclosures do not provide a recovery timeline for the impaired amount or a quantified financial impact from the related-party transfers beyond the ₹0.58 crore outstanding balance.

For shareholders, the immediate factual points are the decline in net worth, the shift from a FY25 profit to a FY26 loss, and the uncertainty over recovery of the customer cash amount. The company has recorded the full impairment, which means the FY26 accounts already reflect its stated uncertainty over collection.

Conclusion

Shanthala FMCG's FY26 results were materially affected by a ₹7.61 crore impairment after a forensic audit found customer cash collections that were not deposited in company bank accounts. The findings resulted in the removal of the former CFO, a qualified opinion from the statutory auditor, and disclosures of ₹5.69 crore in related-party transfers made without stated approvals.

Investors will watch for any update on recovery of the impaired amount, the remaining ₹0.58 crore outstanding from the related-party transfers, and the company's actions to address the audit observations under its new CFO. The disclosures currently do not state a recovery schedule or further financial adjustment plan.